Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07146685 · ClinicalTrials.gov registry record · Phase 4
Effect of Local Anesthetic Concentration on Rebound Pain: A Randomized Control Study
A Phase 4 study, sponsored by University of Virginia.
- Not yet
- Registry status
- Phase 4
- Development phase
- 168
- Enrollment target
NCT07146685 is a Phase 4 study that has not yet begun recruiting, run by University of Virginia. The registered enrollment target is 168 participants.
The verdict
NCT07146685, a Phase 4 study, has not yet begun recruiting, sponsored by University of Virginia.
- NOT YET RECRUITING
- Registry status
- Phase 4
- Development phase
- 168 participants
- Enrollment target
Study Summary
Randomized control study that compares different concentrations of local anesthetic to investigate whether a lower concentration of local anesthetic would contribute to lower rebound pain scores at 24 hours post op in patients undergoing anatomic or reverse total shoulder arthroplasty.
Interventions
- DRUG Bupivacaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 168 participants |
| Start Date | 2026-01-01 |
| Est. Completion | 2029-01-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07146685
The ClinicalTrials.gov registry entry for NCT07146685 describes a study currently listed as not yet recruiting, categorized as Phase 4. The registered enrollment target is 168 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Bupivacaine is the first listed.
NCT07146685 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07146685 about?
NCT07146685 is a clinical study titled "Effect of Local Anesthetic Concentration on Rebound Pain: A Randomized Control Study". Randomized control study that compares different concentrations of local anesthetic to investigate whether a lower concentration of local anesthetic would contribute to lower rebound pain scores at 24 hours post op in patients undergoing anatomic or reverse total shoulder arthroplasty.
What is the current status of trial NCT07146685?
This trial is currently not yet recruiting. It is a Phase 4 study. The enrollment target is 168 participants. The study started on 2026-01-01. Estimated completion is 2029-01-01.
What interventions are being tested in trial NCT07146685?
The interventions under investigation include: Bupivacaine (DRUG).
Who is sponsoring clinical trial NCT07146685?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.